[Federal Register Volume 59, Number 7 (Tuesday, January 11, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-582]
[[Page Unknown]]
[Federal Register: January 11, 1994]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Program Announcement Number 409]
Grants for Injury Prevention Research for Violence Against Women;
Availability of Funds for Fiscal Year 1994
Introduction
The Centers for Disease Control and Prevention (CDC) announces that
applications are being accepted for Injury Prevention Research Grants
for Violence Against Women. The Public Health Service (PHS) is
committed to achieving the health promotion and disease prevention
objectives of Healthy People 2000, a PHS-led national activity to
reduce morbidity, mortality and improve the quality of life. This
announcement is related to the area of Violent and Abusive Behavior.
(For ordering a copy of Healthy People 2000, see the Section Where To
Obtain Additional Information.)
Authority
This program is authorized under sections 301 and 391 of the Public
Health Service Act (42 U.S.C. 241 and 280b). Program regulations are
set forth in title 42 of the CFR part 52.
Eligible Applicants
Eligible applicants include all non-profit and for-profit
organizations. Thus state, tribal, and local health departments and
other state, tribal, and local governmental agencies, universities,
colleges, research institutions, and other public and private
organizations, including small, minority and/or woman-owned businesses
are eligible for these research grants. Current holders of CDC injury
control research projects are eligible to apply.
Availability of Funds
Approximately $2.0 million is projected to be available in FY 1994
to fund approximately 5 to 9 grants. The amount of funding actually
available may vary and is subject to change. New grant awards will not
exceed $300,000 per year (including both direct and indirect costs).
Research grant supplements will generally be no more than $75,000
(including both direct and indirect costs). Awards will be made for a
12-month budget period within a project period not to exceed 3 years.
Continuation awards within the project period will be made on the basis
of satisfactory progress demonstrated by investigators at work-in-
progress monitoring workshops, the achievement of workplan milestones
reflected in the continuation application, and the availability of
Federal funds. In addition, continuation awards will be eligible for
increased funding to offset inflationary costs depending upon the
availability of funds.
Purpose
The purposes of this program are:
A. To build the scientific base for the prevention of injuries and
deaths due to violence against women as delineated in Injury Control in
the 1990s: A National Plan for Action. Atlanta: Centers for Disease
Control and Prevention, 1993; Healthy People 2000; Violence in America:
A Public Health Approach; Understanding and Preventing Violence; and
Injury Prevention: Meeting the Challenge (supplement to the American
Journal of Preventive Medicine, (Vol. 5, no. 3, 1989);
B. To identify effective strategies to prevent injuries and deaths
due to violence against women;
C. To expand the development and evaluation of current and new
intervention methods and strategies for the primary prevention of
violence against women;
D. To encourage professionals from a wide spectrum of disciplines
such as medicine, health care, public health, criminal justice,
behavioral and social sciences, and others to undertake research to
prevent and control injuries that result from violence against women.
Program Requirements
The following are applicant requirements:
A. A principal investigator who has conducted research, published
the findings, and has specific authority and responsibility to carry
out the proposed project.
B. Demonstrated experience in conducting, evaluating, and
publishing injury control research on the applicant's project team.
C. Effective and well-defined working relationships within the
performing organization and with outside entities which will ensure
implementation of the proposed activities.
D. An explanation of how research findings could lead to the
development of injury control interventions within 3-5 years of project
start-up. Furthermore, how the research findings might be disseminated
and implemented through organizations (such as public health agencies)
or systems, both public and private.
E. The ability to carry out injury control research projects.
F. The overall match between the applicant's proposed theme and
research objectives, and the program priorities as described under the
heading ``Programmatic Interest'' and in Injury Control in the 1990s: A
National Plan for Action. Atlanta: Centers for Disease Control and
Prevention, 1993; Healthy People 2000; Violence in America: A Public
Health Approach; Understanding and Preventing Violence; and Injury
Prevention: Meeting the Challenge.
Note: Grant funds will not be made available to support the
provision of direct care services. Eligible applicants may enter
into contracts, including consortia agreements (as set forth in the
PHS Grants Policy Statement) as necessary to meet the requirements
of the program and strengthen the overall application.
Programmatic Interests
The grants should concentrate on the need to prevent the morbidity,
mortality, and disability which result from violence against women, in
order to reduce the devastating social and economic impact on the
nation. Applicants are encouraged to propose research which either: (1)
Rigorously evaluates the outcomes of violence prevention strategies
currently in use, or (2) identifies modifiable risk factors which can
lead to the development of effective interventions. Examples of
possible projects listed under the priority areas below are by no means
exhaustive, and innovative approaches are encouraged. Because of time
constraints, comments were not solicited from the general public
regarding funding priorities and special considerations.
In prevention, there is specific interest in research that
evaluates the effectiveness of interventions to prevent injuries and
deaths due to violence against women, or reduce their impact. There is
also interest in research that develops the basic sciences of injury
control (i.e., social and behavioral sciences, and epidemiology). This
research might evaluate one or more different approaches to
implementing a specific intervention strategy. In addition, there is a
need to examine intervention strategies for which evidence of
effectiveness is either sparse or totally lacking. Interventions chosen
for evaluation should have a significant potential for reducing
morbidity, mortality, disability, or cost. Special consideration will
be given to grants which target populations at high risk for violence-
related injuries and their consequences, including adolescents,
children, racial and ethnic minorities, urban residents, and people
with low incomes.
Examples of strategies for preventing violence against women which
need to be rigorously evaluated for impact on violent outcomes include:
Establishing protocols for early identification and
referral of abuse victims in health settings (e.g., Are women who are
identified as being physically or sexually abused through victim
identification and referral protocols in hospital emergency
departments, substance abuse and mental health centers, STD clinics, or
prenatal care clinics less likely than others to experience future
abuse? Do home health visits reduce partner abuse in targeted families
and, as a consequence, reduce the likelihood that children will witness
such violence?);
Batterer treatment programs;
Alcohol and drug abuse treatment services for batterers
and victims in tandem with batterer treatment programs;
Public information and awareness campaigns to change
attitudes and beliefs which perpetuate violence against women (e.g.,
Can well-designed and administered public awareness campaigns change
knowledge and attitudes that perpetuate violence against women? Are
hotlines that provide crisis intervention counseling an effective
mechanism for increasing the use of available services and programs?)
In epidemiology, there is programmatic interest in analytic
research that identifies mechanisms, causes, or risks of injury which
might lead to new or more effective interventions for violence against
women. Examples of potentially modifiable risk factors which should be
examined for each area are listed below:
Attitudes and beliefs which influence violent behavior
against women (e.g., Are boys and men who hold attitudes conducive to
violence against women more likely to be violent towards women? What
role does culture play in perpetuating these attitudes?);
The impact of early childhood experiences of violence
(either as a witness or victim of violence) upon the tendency to
develop violent behavior patterns in adulthood (e.g., What childhood
experiences mitigate the harmful effects on children of witnessing
violent acts against women? What role does past exposure to varying
forms of violence play in repeated victimization?);
The role of alcohol and other drugs among batterers and
their victims;
Factors in a dating relationship which precipitate violent
behavior (e.g., Are young men who commit violent acts against a date
likely to continue these behaviors?);
Factors which precipitate battering during pregnancy.
Also of programmatic interest is epidemiologic research having as
its focus the development of improved methods for and the evaluation of
injury surveillance systems that accurately quantify the incidence and
severity of injuries that result from violence against women (e.g.,
emergency department-based surveillance of injuries due to violence
against women). Research is needed that more accurately defines the
cost of violence against women, from a social, physical, and
psychological perspective (e.g., How does violence against women affect
productivity in the workplace? How does such violence affect the cost
of health care in general?).
Cost analysis should be included in the plans, where appropriate,
to evaluate an intervention(s) that addresses violence against women. A
more complete discussion of methodologies for assessing cost analysis
is presented in, A Framework for Assessing the Effectiveness of Disease
and Injury Prevention, (CDC, Morbidity and Mortality Weekly Report,
March 27, 1992, Volume 41, Number RR-3, pages 5-11). (To receive
information on these reports see the section Where To Obtain Additional
Information.)
Evaluation Criteria
Upon receipt, applications will be screened by CDC staff for
completeness and responsiveness as outlined under the previous heading,
Program Requirements (A-F). Incomplete applications and applications
that are not responsive will be returned to the applicant without
further consideration. Applications which are complete and responsive
may be subjected to a preliminary evaluation by a peer review group to
determine if the application is of sufficient technical and scientific
merit to warrant further review; the CDC will withdraw from further
consideration applications judged to be noncompetitive and promptly
notify the principal investigator/program director and the official
signing for the applicant organization. Those applications judged to be
competitive will be further evaluated by a dual review process. The
primary review will be a peer evaluation by the Injury Research Grants
Review Committee (IRGRC) of the scientific and technical merit of the
application. The final review will be conducted by the CDC Advisory
Committee for Injury Prevention and Control (ACIPC), which will
consider the results of the peer review together with program need and
relevance. Funding decisions will be made by the Director, National
Center for Injury Prevention and Control (NCIPC), based on merit and
priority score ranking by the IRGRC, program review by the ACIPC, and
the availability of funds.
A. The first review will be a peer review to be conducted on all
applications. Factors to be considered will include:
1. The specific aims of the research project, i.e., the broad long-
term objectives, the intended accomplishment of the specific research
proposal, and the hypothesis to be tested;
2. The background of the proposal, i.e., the basis for the present
proposal, the critical evaluation of existing knowledge, and specific
identification of the injury control knowledge gaps which the proposal
is intended to fill;
3. The significance and originality from a scientific or technical
standpoint of the specific aims of the proposed research, including the
adequacy of the theoretical and conceptual framework for the research;
4. For competitive renewal and supplemental applications, the
progress made during the prior project period. For new applications,
(optional) the progress of preliminary studies pertinent to the
application.
5. The adequacy of the proposed research design, approaches, and
methodology to carry out the research, including quality assurance
procedures, plan for data management, and statistical analysis plan.
6. The extent to which the evaluation plan will allow for the
measurement of progress toward the achievement of the stated
objectives.
7. Qualifications, adequacy, and appropriateness of personnel to
accomplish the proposed activities.
8. The degree of commitment and cooperation of other interested
parties (as evidenced by letters detailing the nature and extent of the
involvement).
9. The reasonableness of the proposed budget to the proposed
research and demonstration program.
10. Adequacy of existing and proposed facilities and resources.
B. The second review will be conducted by the Advisory Committee
for Injury Prevention and Control. The factors to be considered will
include:
1. The results of the peer review.
2. The significance of the proposed activities in relation to the
objectives stated in Injury Control in the 1990s: A National Plan for
Action. Atlanta: Centers for Disease Control and Prevention, 1993;
Healthy People 2000; Violence in America: A Public Health Approach;
Understanding and Preventing Violence; and Injury Prevention: Meeting
the Challenge.
3. National needs.
4. Overall distribution among:
The major disciplines of violence-related injury
prevention: social and behavioral sciences, and epidemiology;
Populations addressed (e.g., adolescents, minorities, the
elderly, urban, rural); and
5. Budgetary considerations (e.g., preference may be given to
applicants who submit proposals requesting funding for research
projects of one to two years) .
C. Continued funding. Continuation awards made after FY 1994, but
within the project period, will be made on the basis of the
availability of funds and the following criteria:
1. The accomplishments reflected in the progress report of the
continuation application indicate that the applicant is meeting
previously stated objectives or milestones contained in the project's
annual workplan and satisfactory progress demonstrated through
monitoring presentations or work-in-progress workshops;
2. The objectives for the new budget period are realistic,
specific, and measurable;
3. The methods described will clearly lead to achievement of these
objectives;
4. The evaluation plan will allow management to monitor whether the
methods are effective; and
5. The budget request is clearly explained, adequately justified,
reasonable and consistent with the intended use of grant funds.
D. Supplementary funding. Competing Supplemental grant awards may
be made when funds are available, to support research work or
activities not previously approved by the Injury Research Grants Review
Committee (IRGRC). Applications should be clearly labelled to denote
their status as requesting supplemental funding support. These
applications will be reviewed by the IRGRC and the secondary review
group.
Executive Order 12372 Review
Applications are not subject to the review requirements of
Executive Order 12372, entitled Intergovernmental Review of Federal
Programs.
Public Health System Reporting Requirement
This program is not subject to the Public Health System Reporting
Requirements.
Catalog of Federal Domestic Assistance Number (CFDA)
The Catalog of Federal Domestic Assistance number is 93.136.
Application Submission and Deadline
A. Preapplication Letter of Intent
Although not a prerequisite of application, a non-binding letter of
intent-to-apply is requested from potential applicants. The letter
should be submitted to the Grants Management Officer (whose address is
reflected in section B, ``Applications''). It should be postmarked no
later than one month prior to the planned submission deadline, (e.g.,
February 15 for March 15 submission). The letter should identify the
specific program announcement number, indicate the intended submission
deadline, and include the name of the principal investigator. The
letter of intent does not influence review or funding decisions, but it
will enable CDC to plan the review more efficiently, and will ensure
that each applicant receives timely and relevant information prior to
application submission.
B. Applications
Applicants should use Form PHS-398 and adhere to the ERRATA
Instruction Sheet for Form PHS-398 contained in the Grant Application
Kit. Please submit an original and five copies, on or before March 15,
1994 to: Henry S. Cassell, III, Grants Management Officer, Grants
Management Branch, Procurement and Grants Office, Centers for Disease
Control and Prevention (CDC), 255 East Paces Ferry Road, NE., room 300,
Atlanta, Georgia 30305.
C. Deadlines
1. Applications shall be considered as meeting the deadline if they
are either:
A. Received at the above address on or before the deadline date, or
B. Sent on or before the deadline date to the above address, and
received in time for submission for the review process. Applicants
should request a legibly dated U.S. Postal Service postmark or obtain a
legibly dated receipt from a commercial carrier or the U.S. Postal
Service. Private metered postmarks shall not be acceptable as proof of
timely mailings.
2. Applications which do not meet the criteria in 1.A. or 1.B.
above are considered late applications and will be returned to the
applicant.
Where To Obtain Additional Information
To receive additional information, call (404) 332-4561. You will be
asked to leave your name, address, and phone number and will need to
refer to Announcement Number 409. You will receive a complete program
description, information on application procedures, and application
forms. If you have questions after reviewing the contents of all
documents, business management technical assistance may be obtained
from Lisa Tamaroff, Grants Management Specialist, Procurement and
Grants Office, Centers for Disease Control and Prevention (CDC), 255
East Paces Ferry Road, NE., room 300, Atlanta, GA 30305, (404) 842-
6796. Programmatic technical assistance may be obtained from Ted Jones,
Project Officer, Extramural Research Grants Branch, National Center for
Injury Prevention and Control, Centers for Disease Control and
Prevention (CDC), Mailstop K-58, 4770 Buford Highway, NE., Atlanta,
Georgia 30341-3724, (404) 488-4824.
Potential applicants may obtain a copy of Healthy People 2000 (Full
Report, Stock No. 017-001-00474-0) or Healthy People 2000 (Summary
Report, Stock No. 017-001-00473-1) through the Superintendent of
Documents, Government Printing Office, Washington, DC 20402-9325,
telephone (202) 783-3238. Copies of Injury Control in the 1990s: A
National Plan for Action. Atlanta: Centers for Disease Control and
Prevention, 1993; Injury Prevention: Meeting the Challenge; and A
Framework for Assessing the Effectiveness of Disease and Injury
Prevention, (CDC, Morbidity and Mortality Weekly Report, March 27,
1992, Volume 41, Number RR-3, pages 5-11) may be obtained by calling
(404) 488-4646. Also, information for obtaining Violence in America: A
Public Health Approach and Understanding and Preventing Violence can be
received by calling the previously listed phone number (404/488-4646).
Dated: January 4, 1994.
Ladene H. Newton,
Acting Associate Director for Management and Operations, Centers for
Disease Control and Prevention (CDC).
[FR Doc. 94-582 Filed 1-10-94; 8:45 am]
BILLING CODE 4160-18-P
